COMPASS Pathways plc (NASDAQ:CMPS) Q3 2023 Results Conference Call November 2, 2023 8:00 AM ET Company Participants Stephen Schultz - SVP, IR Kabir Nath - CEO Mary-Rose Hughes - Interim CFO Dr. Guy Goodwin - Chief Medical Officer Conference Call Participants Ritu Baral - TD Cohen Charles Duncan - Cantor François Brisebois - Oppenheimer Patrick Trucchio - H.C. Wainright Michael Okunewitch - Maxim Group Sumant Kulkarni - Canaccord Genuity Gavin Clark-Gartner - Evercore ISI Thomas Shrader - BTIG Operator Good ...

Table of Contents • adding new clinical trial sites; • availability of adequately trained therapists and appropriate third-party clinical trial sites for the administration of COMP360 psilocybin treatment in our Phase 3 program and other clinical trials, including preparation, psilocybin administration and integration of the therapeutic experience; • sufficiency of any supporting digital services that may form part of the preparation, integration or long-term follow-up relating to any drug we develop; • fai ...

COMPASS Pathways plc (NASDAQ:CMPS) Q2 2023 Earnings Conference Call August 3, 2023 8:00 AM ET Company Participants Stephen Schultz - Senior Vice President of Investor Relations Kabir Nath - Chief Executive Officer Guy Goodwin - Chief Medical Officer Mike Falvey - Chief Financial Officer Conference Call Participants Ritu Baral - Cowen and Company, LLC Charles Duncan - Cantor Fitzgerald Patrick Trucchio - H.C. Wainwright & Co, LLC Francois Brisebois - Oppenheimer & Co. Elemer Piros - EF Hutton Thomas Shrader ...

• an increase of $0.8 million in non-cash share-based compensation expense due to increased staffing levels year over year and equity awards granted to our chief executive officer in August 2022; and During the six months ended June 30, 2023 and 2022, we recognized an R&D tax credit in the UK as a benefit within other income, net of $6.4 million and $7.0 million, respectively. The tax credit receivable decreased by $0.6 million in 2023 compared to 2022 due to a reduction in the R&D tax relief rates. Up unti ...

COMPASS Pathways plc (NASDAQ:CMPS) Q1 2023 Earnings Conference Call May 11, 2023 8:00 AM ET Company Participants Steve Schultz - Senior Vice President of Investor Relations Kabir Nath - Chief Executive Officer Guy Goodwin - Chief Medical Officer Mike Falvey - Chief Financial Officer Conference Call Participants Elemer Piros - EF Hutton Charles Duncan - Cantor Fitzgerald Frank Brisebois - Oppenheimer & Co. Inc. Joshua Schimmer - Evercore ISI Patrick Trucchio - H.C. Wainwright & Co. Ritu Baral - Cowen and Com ...

Table of Contents advantages to physicians to induce or encourage the prescription, recommendation, endorsement, purchase, supply, order or use of medicinal therapies is also prohibited in most countries within the EU. The provision of benefits or advantages to induce or reward improper performance generally is typically governed by the national anti-bribery laws of EU Member States, and in respect of the UK, the Bribery Act 2010. Infringement of these laws could result in substantial fines and imprisonment ...

COMPASS Pathways plc (NASDAQ:CMPS) Q4 2022 Earnings Conference Call February 28, 2023 8:00 AM ET Company Participants Steven Schultz - Senior Vice President-Investor Relations Kabir Nath - Chief Executive Officer Mike Falvey - Chief Financial Officer Conference Call Participants Charles Duncan - Cantor Fitzgerald Ritu Baral - Cowen François Brisebois - Oppenheimer Patrick Trucchio - H.C. Wainwright Elemer Piros - EF Hutton Group Neena Bitritto-Garg - Citi Bert Hazlett - BTIG Kyle Qian - CGS Operator Good da ...

Commission File Number: 001-39522 +1 (716) 676-6461 (Registrant's telephone number, including area code) If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ The aggregate market value of ordinary ...

COMPASS Pathways plc (NASDAQ:CMPS) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET Company Participants Steven Schultz - SVP, IR George Goldsmith - Co-Founder and Executive Chairman Kabir Nath - CEO Guy Goodwin - Chief Medical Officer Mike Falvey - CFO Conference Call Participants Charles Duncan - Cantor Fitzgerald Neena Bitritto-Garg - Citi Ritu Baral - Cowen Patrick Trucchio - H.C. Wainwright & Company François Brisebois - Oppenheimer Bert Hazlett - BTIG Esther Hong - Loop Capital Sumant Kulk ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ⊠ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 001-39522 COMPASS Pathways plc (Exact name of registrant as specified in its charter) England and Wales Not Applicable ( ...